Nasal airway device for sleep apnea in children with low muscle tone
Tests a self-supporting nasal airway device for sleep apnea in children with low muscle tone.
Key facts
- Who runs it
- University of Michigan
- Where
- Ann Arbor, United StatesSee the site
- Trial code
- Registry title
- Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 16 Nov 2022
- Expected to end
- Aug 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Self-Supporting Nasopharyngeal Airway (ssNPA)
- Record updated
- 19 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and young people with low muscle tone in the upper airway who have obstructive sleep apnea. This is when the airway gets blocked during sleep. It tests a device placed in the nose to keep the airway open.
- Age
- 3 Years to 21 Years
- Sex
- All
- Disease stage
- Newly diagnosed obstructive sleep apnea, confirmed by an overnight sleep study: AHI>10, or AHI>5 with oxygen level (SpO2) dropping to <=75%. At least one symptom is needed, such as snoring 3 or more nights per week, daytime sleepiness, or hyperactive or inattentive behaviour. Tonsil size must be 2+ or smaller.
- Earlier treatment
- Must have already had removal of the tonsils and adenoids, or have a medical reason not to have tonsil removal.
Main reasons for not taking part
- Milder sleep study results than the trial asks for, or a medical reason the nose device cannot be used
- Carbon dioxide levels >60 mmHg for >10% of sleep time on the sleep study
- Narrowing or collapse lower in the airway, or moderate/severe softening of the windpipe (tracheobronchomalacia)
- Bleeding disorder or need for blood-thinning medicine
- Active COVID 19 infection, severe autism, or chest disorders that limit breathing
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Children with Hypotonic Upper Airway Obstruction (HUAO): This includes those who newly diagnosed with obstructive sleep apnea (OSA). These children will undergo overnight polysomnography to determine the presence of OSA (apnea-hypopnea index [AHI]>10 or AHI>5 with nocturnal hypoxemia defined as oxygen saturation by pulse oximetry [SpO2] nadir <=75%)
- All subjects require the presence of at least one symptom of OSA (such as snoring 3 or more nights per week, daytime sleepiness, or hyperactive/inattentive behaviors)
- Post adenotonsillectomy or those with contraindications to tonsillectomy
- Tonsil size 2+ or smaller
- Parent/caregivers willing and able to provide informed consent and child willing and able to provide assent, where appropriate
Who cannot take part
- Any medical reason why Self-Supporting Nasopharyngeal Airway (ssNPA) therapy may not be suitable
- Need for anticoagulative therapy
- Active Coronavirus (COVID) 19 infections
- Psychiatric, medical, or social factors likely to invalidate assessments, make adherence with ssNPA highly unlikely or make local follow-up at 8 weeks unfeasible. Some psychiatric conditions may be provoked or exacerbated by OSA, and those most commonly implicated - Attention Deficit/Hyperactivity Disorder, Conduct Disorder, and Oppositional Defiant Disorder - will not be exclusions. However, more pervasive conditions such as severe autism will be excluded
- Bleeding disorder
- Restrictive thoracic disorders
- AHI ≤10 on polysomnogram (PSG) without hypoxemia or AHI<5 with hypoxemia
- End-tidal carbon dioxide (ETCO2) or Transcutaneous carbon dioxide (TCO2) values >60 mmHg for >10% of sleep time on PSG
- Presence of supraglottic airway collapse or more distal airway stenosis or collapse (for example glottic, subglottic stenosis, or concern for distal airway stenosis or malacia)
- Moderate/severe tracheobronchomalacia
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 21 years old?
Where in United States
- The University of MichiganAnn Arbor, United StatesContact: Louise M O'Brien, PhDTaking people
About the trial
What the trial wants to find out
The researchers are investigating if the Self-Supporting Nasopharyngeal Airway (ssNPA) device can be used in the treatment of obstructive sleep apnea in children with Hypotonic Upper Airway Obstruction (HUAO).
The 2 groups in the trial
- Self-Supporting Nasopharyngeal Airway (ssNPA)Treatment being tested
- Standard of CareNo study treatment, for comparison
Waitlist control group: While waiting, participants will continue to receive the treatment they would have had before which will likely include being placed on the waiting list for positive airway pressure (PAP). After a period of being on the waitlist (8 weeks) there is an option to cross-over to the device arm.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
- Plain-language title
- Nasal airway device for sleep apnea in children with low muscle toneGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05527652, who can take part
- Record updated
- 19 August 2026